
In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
The name of Karthik Aryan, who has made a special place in the hearts of people through his excel
WPI Inflation in India: WPI inflation continues to hit 15.18 percent in June
The wholesale inflation rate in India has also been more than the percentage in June. According t
NASA is about to launch the Artemis 1 mission today through its powerful Orion spacecraft. All th
Amidst the severe cold, a significant drop in the morning temperature was recorded in Delhi on Fr
Within 24 hours of presenting the Punjab model of Congress President Navjot Singh Sidhu, the Aam
The hijab controversy has once again started heating up in Karnataka. Some students of Mangaluru
NTA: NTA has been in the headlines ever since the NEET paper leak. NTA conducts many major examin
South superstar Kamal Haasan has been reprimanded by the Karnataka High Court for making controve
The coalition government of Israel's Prime Minister Naftali Bennett is in crisis. This government
Vijay demands CBI probe after 40 killed in Karur stampede, High Court hearing today
A stampede broke out at actor-turned-politician Vijay's rally in Karur, Tamil Nadu, on Saturday.